You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,248,735


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,248,735
Title: Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a .beta.-adrenergic antagonist
Abstract:Combinations of a .beta.-adrenergic antagonist and a topical carbonic anhydrase inhibitor are particularly useful in the treatment of ocular hypertension, especially in patients insufficiently responsive to treatment with .beta.-adrenergic antagonists.
Inventor(s): Baldwin; John J. (Gwynedd Valley, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/833,067
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,248,735: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for any business or individual involved in intellectual property. This article will delve into the details of United States Patent 6,248,735, focusing on its scope, claims, and the broader patent landscape.

Overview of United States Patent 6,248,735

United States Patent 6,248,735, titled "Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist," was granted for a specific formulation used in ophthalmic treatments. This patent combines two types of drugs to treat conditions such as glaucoma.

Patent Claims

Independent Claims

The independent claims of a patent are the broadest and most critical claims, as they define the core invention. For U.S. Patent 6,248,735, the independent claims would typically include the combination of a carbonic anhydrase inhibitor and a β-adrenergic antagonist in an ophthalmic composition, along with any specific ratios or formulations that are novel and non-obvious.

Dependent Claims

Dependent claims build upon the independent claims and provide more specific details about the invention. These might include specific concentrations of the active ingredients, methods of administration, or particular uses of the ophthalmic composition.

Scope of the Patent

Technical Scope

The technical scope of U.S. Patent 6,248,735 is limited to ophthalmic compositions that include both a carbonic anhydrase inhibitor and a β-adrenergic antagonist. This scope is defined by the chemical structures of the compounds, their concentrations, and the method of application.

Geographical Scope

The geographical scope is limited to the United States, as it is a U.S. patent. However, similar patents may exist in other countries, and international patent applications might have been filed under the Patent Cooperation Treaty (PCT) through the World Intellectual Property Organization (WIPO)[4].

Patent Landscape Analysis

Competitive Landscape

To understand the competitive landscape, one must analyze other patents in the same field. This involves searching databases such as the USPTO's Patent Public Search, the European Patent Office's esp@cenet, and WIPO's PATENTSCOPE. These databases provide access to published patent applications and granted patents worldwide, allowing for a comprehensive analysis of similar inventions and potential competitors[1][4].

Claim Coverage Matrix

A Claim Coverage Matrix, as described by Schwegman, can help in categorizing patents by claims and scope concepts. This matrix is particularly useful for identifying which patents and claims are actively protecting the intellectual property related to ophthalmic compositions. It highlights gaps or opportunities in the current claim coverage and can guide future design and development strategies[3].

Global Dossier

Using the Global Dossier service provided by the USPTO, one can access the file histories of related applications from participating IP Offices. This service helps in identifying the patent family for a specific application, including classification, citation data, and office actions. This information is crucial for understanding the global patent landscape and potential challenges or opportunities[4].

Searching and Analyzing Patents

Tools and Resources

Several tools and resources are available for searching and analyzing patents:

  • Patent Public Search: A web-based tool that provides enhanced access to prior art and replaces legacy search tools like PubEast and PubWest[4].
  • Cooperative Patent Classification (CPC): A system used to classify patents, which can be searched to find relevant classification schemes[1].
  • PATENTSCOPE: Provides full-text search of published international patent applications and machine translations for some documents[1].

Training and Assistance

The USPTO offers various training materials and resources, including the Patent and Trademark Resource Centers (PTRCs) and the Public Search Facility in Alexandria, VA. These resources can help in conducting preliminary patent searches and understanding the patent landscape more effectively[4].

Claim Charts and Scope Concepts

Claim charts generated by tools like ClaimScape® can help in reviewing patent coverage with technical experts. These charts categorize claims by scope concepts, making it easier to determine whether a particular scope concept is applicable to a target product or method. This approach helps in identifying gaps in current coverage and highlighting future design opportunities[3].

Future Design Opportunities

By analyzing the scope concepts and claim coverage, businesses can identify areas where they do not have the necessary claim coverage. This analysis can guide new design options and future development strategies, ensuring that the intellectual property is adequately protected.

Maintenance and Updates

Patent claims and scope concepts need to be regularly updated as new patents are filed or as development avenues are explored. This ensures that the patent landscape remains current and that any gaps in coverage are addressed promptly.

Key Takeaways

  • Understand the Claims: Independent and dependent claims define the core invention and its specifics.
  • Analyze the Scope: Technical and geographical scopes are crucial for understanding the patent's limitations.
  • Use Advanced Tools: Tools like Patent Public Search, CPC, and PATENTSCOPE are essential for comprehensive patent landscape analysis.
  • Claim Coverage Matrix: Helps in identifying gaps and opportunities in claim coverage.
  • Regular Updates: Ensure that the patent landscape remains current and that any gaps are addressed.

FAQs

What is the main focus of U.S. Patent 6,248,735?

The main focus of U.S. Patent 6,248,735 is on ophthalmic compositions that combine a carbonic anhydrase inhibitor and a β-adrenergic antagonist.

How can I search for similar patents globally?

You can use databases like the USPTO's Patent Public Search, the European Patent Office's esp@cenet, and WIPO's PATENTSCOPE to search for similar patents globally[1][4].

What is a Claim Coverage Matrix?

A Claim Coverage Matrix categorizes patents by claims and scope concepts, helping to identify gaps or opportunities in current claim coverage and guiding future design strategies[3].

Where can I get training on patent searching?

The USPTO provides training materials and resources through the Patent and Trademark Resource Centers (PTRCs) and the Public Search Facility in Alexandria, VA[4].

How often should I update my patent claims and scope concepts?

Patent claims and scope concepts should be regularly updated as new patents are filed or as development avenues are explored to ensure the patent landscape remains current.

Sources

  1. Clemson University Libraries: Advanced Patent Searching Guide.
  2. USA.gov: U.S. Patent and Trademark Office.
  3. Schwegman Lundberg & Woessner: Patent Analytics.
  4. USPTO: Search for Patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,248,735

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,248,735

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0509752 ⤷  Subscribe CA 2000 00002 Denmark ⤷  Subscribe
European Patent Office 0509752 ⤷  Subscribe C990041 Netherlands ⤷  Subscribe
European Patent Office 0509752 ⤷  Subscribe SPC/GB99/043 United Kingdom ⤷  Subscribe
European Patent Office 0509752 ⤷  Subscribe 2000C/001 Belgium ⤷  Subscribe
European Patent Office 0509752 ⤷  Subscribe 49/1999 Austria ⤷  Subscribe
Austria 182787 ⤷  Subscribe
Australia 1497992 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.